-

Syncell Showcases Pioneering Microscopy-Guided Subcellular Protein Scooping Technology at the AACR Annual Meeting 2023

TAIPEI, Taiwan & LOS ALTOS, Calif.--(BUSINESS WIRE)--Syncell, a biotech company pioneering in platforms for hypothesis-free spatial proteomics, will be exhibiting and presenting a poster at the AACR Annual Meeting 2023 in Orlando, FL. Syncell’s Microscoop technology enables microscopy-guided subcellular protein scooping in ultra-content powered by AI to collect enough proteins for subsequent spatial proteomic identification. Syncell announces that Microscoop Mint, the first commercial Microscoop platform of Syncell, will be available for order. Earlier this year, Syncell also announced expansion of its Global Rapid Access Service Program (GRASP) to use Microscoop.

“Syncell’s Microscoop technology is not really a spatial proteomic mapping technology, it is a direct spatial proteomic discovery technology to help researchers identify novel protein biomarkers. We are excited to see the high demands of services for diverse life science problems. We are happy to see recent successful proteomic discovery for customers’ research projects. We believe Microscoop technology will also be broadly useful for cancer research,” said Dr. JC Liao, the Founder and CEO of Syncell.

Details of the technology and the new product will be showcased at Syncell’s exhibit hall booth (#129). A poster will be presented on April 18, 2023 @ 1:30 PM - 5:00 PM at Section 23 titled “Total-Sync Ultra-Content Microscopic Opto-Biotinylation Enables High-Sensitivity Hypothesis-Free Subcellular Protein Discovery”. Copies of the poster will also be available at the booth.

About Syncell
Syncell is a biotech company pioneering in platforms and methodology for hypothesis-free spatial proteomics and protein biomarker discovery. Syncell’s Microscoop technology enables disruptive microscopy-guided subcellular protein scooping and identification, making high-precision spatial biomarker discovery possible. Syncell’s mission is to broadly benefit customers in academia, pharmaceutical industry, and medical institutes by delivering innovative instruments and reagents as well as establishing biomarker discovery partnerships.

Contacts

Primary Contact
Jennie Wu
JennieWu@syncell.com

Industry:

Syncell

Release Versions
English

Contacts

Primary Contact
Jennie Wu
JennieWu@syncell.com

More News From Syncell

Syncell Welcomes New Management Team Members, Philippe Lyko and Nikhil Rao

TAIPEI, Taiwan & WATERTOWN, Mass.--(BUSINESS WIRE)--Syncell, a leader in next-generation spatial proteomics, is pleased to announce the addition of Philippe C. Lyko as Chief Financial Officer (CFO) and Nikhil Rao, PhD, as Senior Vice President of Commercial. These appointments strengthen Syncell's leadership team as the company enters a pivotal phase of growth and commercial expansion. Philippe Lyko joins Syncell following a successful tenure at DNA Script, a pioneer in Enzymatic DNA Synthesis...

Syncell Expands Into the United States With a New Office in Watertown, MA

TAIPEI, Taiwan & WATERTOWN, Massachusetts--(BUSINESS WIRE)--Syncell opens first U.S. office showcasing Microscoop's revolutionary proteomic technology. Watertown site supports GRASP and features demo center....

Syncell Appoints Life Science Industry Leaders Dr. Martin Madaus and Dr. Don Kania as Business Strategic Advisors

TAIPEI, Taiwan & LOS ALTOS, Calif.--(BUSINESS WIRE)--Syncell, a life science technology company developing tools for next-generation proteome research, proudly announces the appointment of Dr. Martin Madaus and Dr. Don Kania as the new Business Strategic Advisors of the company. With their extensive backgrounds in the life science industry, both Dr. Madaus and Dr. Kania will guide Syncell's growth and innovation, helping the company become a major player in the spatial proteomics industry. Dr....
Back to Newsroom